Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mangalam Drugs & Organics Ltd. ( (IN:MANGALAM) ) has issued an update.
Mangalam Drugs & Organics Ltd. announced its unaudited financial results for the quarter ending June 30, 2025, reporting a net loss of Rs. 1,372.80 lakhs, a significant decline compared to a profit in the previous year. The company’s financial performance reflects challenges in the market, with decreased sales and increased expenses impacting profitability, which may concern stakeholders and investors.
More about Mangalam Drugs & Organics Ltd.
Mangalam Drugs & Organics Ltd. operates in the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and intermediates. The company is headquartered in Mumbai, India, and has a manufacturing facility in Vapi, Gujarat.
Average Trading Volume: 6,062
Technical Sentiment Signal: Sell
Current Market Cap: 1.32B INR
For a thorough assessment of MANGALAM stock, go to TipRanks’ Stock Analysis page.